1. WHO. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva; 2015 [cited 2016 Jul 9]. 78 p. Available from: http://www.ncbi.nlm.nih.gov/books/NBK327115/
2. UNAIDS. AIDS-by-the-numbers-2016. Aids is not over, but it can be. [Internet]. Geneva; 2016 [cited 2017 May 25] p. 28. Available from: http://www.unaids.org/sites/default/files/media_asset/AIDS-by-the-numbers-2016_en.pdf
3. WHO. WHO HIV drug resistance report, 2012 [Internet]. Geneva, Switzerland: World Health Organization; 2012 [cited 2017 Jan 24]. Available from: http://apps.who.int/iris/bitstream/10665/75183/1/9789241503938_eng.pdf
4. Laborde-Balen G, Taverne B, Ndour CT, et al. The fourth HIV epidemic. Lancet Infect Dis. 2018;18:379–80.
5. Gupta RK, Gregson J, Parkin N, et al. HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis. Lancet Infect Dis. 2018;18:346–55.